Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...